The global Plant Stem Cells Market, valued at US$ 396.1 million in 2023, is poised for robust expansion, projected to reach a market size of US$ 855.3 million by 2032. This growth ...

Kwame was only 29 when he was told he needed spinal surgery. Years of back pain had worsened into something unbearable—his ...

I Peace, Inc. ( a global pioneer in iPSC (induced pluripotent stem cell) technology, proudly announces the launch of its personalized iPS cell production and longevity-focused rejuvenation therapies ...

Stem cell treatment using reprogrammed cells shows promising in helping paralyzed individuals regain lost functions.

Dr. Davies Kofie Adedze, a leading advocate for regenerative medicine, has stated that stem cell therapy could significantly ...

Researchers at Tokyo's Keio University are conducting their study using induced pluripotent stem cells (iPS) -- created by ...

Mesoblast develops allogeneic products based on its proprietary remestemcel-L and rexlemestrocel-L mesenchymal lineage stromal and precursor cell platform technologies. Its allogeneic cellular ...

Professor Kenji Osafune (Department of Cell Growth and Differentiation) and his team of researchers have devised an effective ...

Parse Biosciences, the leading provider of accessible and scalable single cell sequencing solutions, today announced an agreement with Tokyo-based SCRUM Inc. to expand its presence in Japan's research ...

Scientists at Japan's Keio University have pioneered a stem cell therapy that enables paralyzed individuals to regain motor ...

Japan’s leading chemical producers are in the midst of a restructuring intended to shift their focus from traditional ...

A multi-institutional team led by The University of Osaka developed a chimeric antigen receptor (CAR) T cell-based strategy ...